Entity Details

Primary name XPP3_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9NQH7
EntryNameXPP3_HUMAN
FullNameXaa-Pro aminopeptidase 3
TaxID9606
Evidenceevidence at protein level
Length507
SequenceStatuscomplete
DateCreated2006-10-31
DateModified2021-06-02

Ontological Relatives

GenesXPNPEP3

GO terms

Show/Hide Table
GOName
GO:0003094 glomerular filtration
GO:0004177 aminopeptidase activity
GO:0005737 cytoplasm
GO:0005739 mitochondrion
GO:0005829 cytosol
GO:0006508 proteolysis
GO:0008233 peptidase activity
GO:0016485 protein processing
GO:0030145 manganese ion binding
GO:0042803 protein homodimerization activity
GO:0070006 metalloaminopeptidase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Mitochondrion

Domains

Show/Hide Table
DomainNameCategoryType
IPR000994 Peptidase M24DomainDomain
IPR007865 Aminopeptidase P, N-terminalDomainDomain
IPR029149 Creatinase/Aminopeptidase P/Spt16, N-terminalFamilyHomologous superfamily
IPR036005 Creatinase/aminopeptidase-likeFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613159 OMIMNephronophthisis-like nephropathy 1 (NPHPL1)A disorder with features of nephronophthisis, a cystic kidney disease leading to end-stage renal failure. Nephronophthisis is histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. Typical clinical manifestation are chronic renal failure, anemia, polyuria, polydipsia, isosthenuria, and growth retardation. Associations with extrarenal symptoms are frequent. In NPHPL1 patients, extrarenal symptoms include hypertension, essential tremor, sensorineural hearing loss and gout. Severely affected individuals can manifest a mitochondrial disorder with isolated complex I deficiency activity in muscle, seizures, mental retardation and hypertrophic dilated cardiomyopathy. The disease is caused by variants affecting the gene represented in this entry.